Industry: Chemical & Material
Published Date: 2025-05-01
Pages: 143 Pages
Report ld: 4720623
Request Sample
Customized Report
Piperazine Market Size(US$)

CAGR 2025-2031
3.1%
Market Size,2031
USD 107
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Piperazine market is projected to grow from US$ 89.3 million in 2025 to US$ 107 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.
The evolving U.S. tariff policy posed substantial volatility risks to global markets. This report provides a comprehensive assessment of trade barrier escalations and cross-border counterstrategies, analyzing their multidimensional impacts on industrial competition patterns, geo-economic integration, and transnational value chain realignments.
Piperazine (C₄H₁₀N₂) is a vital organic chemical typically presented as a white crystalline powder, highly soluble in water and many organic solvents. Known for its mild basicity and excellent chemical reactivity, piperazine finds broad applications across pharmaceuticals, agrochemicals, rubber, resins, coatings, fiber production, and coolant industries. In the pharmaceutical sector, it serves as a crucial intermediate for synthesizing various anthelmintic drugs, especially for treating roundworm and tapeworm infections. In the chemical industry, piperazine and its derivatives are essential in the production of polymers, epoxy resin curing agents, and gas treatment aids, including CO₂ capture agents. In recent years, due to its unique structural properties, piperazine has also been increasingly utilized in drug discovery and functional material research, making it an indispensable raw material within the chemical and pharmaceutical supply chain.
In recent years, the global piperazine market has exhibited steady growth, driven by multiple converging factors. Firstly, the increasing global population and improvements in healthcare access have led to a rising demand for antiparasitic treatments, particularly in developing regions such as Africa, Southeast Asia, and South America, where parasitic infections like roundworms and tapeworms remain prevalent. This has directly fueled the market demand for piperazine-based anthelmintic drugs. Secondly, industrial applications of piperazine have expanded notably, especially in gas treatment sectors. Piperazine and its derivatives are employed as highly effective agents for carbon dioxide capture, aligning with global decarbonization efforts and green development trends. Additionally, as a critical raw material for epoxy resin curing agents, piperazine is seeing growing demand in high-performance composite materials used in aerospace, automotive, and advanced manufacturing industries.
The Asia-Pacific region, particularly China, dominates the production and consumption landscape, collectively accounting for over 45% of the global market share. China's comprehensive chemical supply chain infrastructure and relatively lower production costs position it as a key exporter of piperazine worldwide. In contrast, the United States and Europe mainly focus on pharmaceutical-grade and high-end specialty chemical segments, where requirements for product purity, quality consistency, and environmental compliance are more stringent.
Notably, increasingly stringent environmental regulations have significantly impacted the development of the piperazine market. Initiatives such as the EU's REACH Regulation, the U.S. EPA guidelines, and China's green transformation policies for the chemical industry are compelling manufacturers to upgrade production processes, minimize harmful by-products, enhance product purity, and adopt greener and safer raw materials. Moreover, research into bio-based piperazine and ultra-high-purity piperazine is accelerating, and these segments are expected to create new competitive dynamics in the coming years.
Looking forward, the global piperazine market is poised for sustained growth, driven by expanding applications in pharmaceuticals, environmental solutions, and advanced materials. Leading companies such as BASF, Dow Chemical, Yantai Hengyuan, and Nanjing Special Chemical are actively expanding production capacities and upgrading product portfolios to capture emerging opportunities. Strategic focus areas will include innovation in eco-friendly production technologies, exploration of high-value downstream applications, and expansion into untapped markets where healthcare infrastructure and industrial needs are evolving rapidly.
In terms of production side, this report researches the Piperazine production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of Piperazine by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Piperazine, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Piperazine, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Piperazine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Piperazine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Piperazine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Piperazine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Akzo Nobel, Dow Chemicals, BASF, Tosoh, Delamine, Nippon Nyukazai, Diamines And Chemicals Limited (DACL), Hebei Hejia Pharmaceutical Group, Shaoxing Xingxin New Materials Co.,Ltd, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Piperazine production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Piperazine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Piperazine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Piperazine sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Piperazine Product Introduction
1.2 Market by Type
1.2.1 Global Piperazine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Anhydrous Piperazine
1.2.3 68 Piperazine
1.2.4 Other
1.3 Market by Application
1.3.1 Global Piperazine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Industry
1.3.3 Chemical Industry
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Piperazine Production
2.1 Global Piperazine Production Capacity (2020-2031)
2.2 Global Piperazine Production by Region: 2020 VS 2024 VS 2031
2.3 Global Production by Region
2.3.1 Global Piperazine Production by Region (2020-2031)
2.3.2 Global Piperazine Production Market Share by Region (2020-2031)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Piperazine Revenue Estimates and Forecasts 2020-2031
3.2 Global Revenue by Region
3.2.1 Global Piperazine Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Piperazine Revenue by Region (2020-2031)
3.2.3 Global Piperazine Revenue Market Share by Region (2020-2031)
3.3 Global Piperazine Sales Estimates and Forecasts 2020-2031
3.4 Global Sales by Region
3.4.1 Global Piperazine Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Piperazine Sales by Region (2020-2031)
3.4.3 Global Piperazine Sales Market Share by Region (2020-2031)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufacturers
4.1 Global Sales by Manufacturers
4.1.1 Global Piperazine Sales by Manufacturers (2020-2025)
4.1.2 Global Piperazine Sales Market Share by Manufacturers (2020-2025)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Piperazine in 2024
4.2 Global Revenue by Manufacturers
4.2.1 Global Piperazine Revenue by Manufacturers (2020-2025)
4.2.2 Global Piperazine Revenue Market Share by Manufacturers (2020-2025)
4.2.3 Global Top 10 and Top 5 Companies by Piperazine Revenue in 2024
4.3 Global Piperazine Sales Price by Manufacturers (2020-2025)
4.4 Global Key Players of Piperazine, Industry Ranking, 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Piperazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Piperazine, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Piperazine, Product Offered and Application
4.8 Global Key Manufacturers of Piperazine, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Sales by Type
5.1.1 Global Piperazine Historical Sales by Type (2020-2025)
5.1.2 Global Piperazine Forecasted Sales by Type (2026-2031)
5.1.3 Global Piperazine Sales Market Share by Type (2020-2031)
5.2 Global Revenue by Type
5.2.1 Global Piperazine Historical Revenue by Type (2020-2025)
5.2.2 Global Piperazine Forecasted Revenue by Type (2026-2031)
5.2.3 Global Piperazine Revenue Market Share by Type (2020-2031)
5.3 Global Price by Type
5.3.1 Global Piperazine Price by Type (2020-2025)
5.3.2 Global Piperazine Price Forecast by Type (2026-2031)
6 Market Size by Application
6.1 Global Sales by Application
6.1.1 Global Piperazine Historical Sales by Application (2020-2025)
6.1.2 Global Piperazine Forecasted Sales by Application (2026-2031)
6.1.3 Global Piperazine Sales Market Share by Application (2020-2031)
6.2 Global Revenue by Application
6.2.1 Global Piperazine Historical Revenue by Application (2020-2025)
6.2.2 Global Piperazine Forecasted Revenue by Application (2026-2031)
6.2.3 Global Piperazine Revenue Market Share by Application (2020-2031)
6.3 Global Price by Application
6.3.1 Global Piperazine Price by Application (2020-2025)
6.3.2 Global Piperazine Price Forecast by Application (2026-2031)
7 US & Canada
7.1 US & Canada Market Size by Type
7.1.1 US & Canada Piperazine Sales by Type (2020-2031)
7.1.2 US & Canada Piperazine Revenue by Type (2020-2031)
7.2 US & Canada Market Size by Application
7.2.1 US & Canada Piperazine Sales by Application (2020-2031)
7.2.2 US & Canada Piperazine Revenue by Application (2020-2031)
7.3 US & Canada Market Size by Country
7.3.1 US & Canada Piperazine Revenue by Country: 2020 VS 2024 VS 2031
7.3.2 US & Canada Piperazine Revenue by Country (2020-2031)
7.3.3 US & Canada Piperazine Sales by Country (2020-2031)
7.3.4 US
7.3.5 Canada
8 Europe
8.1 Europe Market Size by Type
8.1.1 Europe Piperazine Sales by Type (2020-2031)
8.1.2 Europe Piperazine Revenue by Type (2020-2031)
8.2 Europe Market Size by Application
8.2.1 Europe Piperazine Sales by Application (2020-2031)
8.2.2 Europe Piperazine Revenue by Application (2020-2031)
8.3 Europe Market Size by Country
8.3.1 Europe Piperazine Revenue by Country: 2020 VS 2024 VS 2031
8.3.2 Europe Piperazine Sales by Country (2020-2031)
8.3.3 Europe Piperazine Revenue by Country (2020-2031)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Market Size by Type
9.1.1 China Piperazine Sales by Type (2020-2031)
9.1.2 China Piperazine Revenue by Type (2020-2031)
9.2 China Market Size by Application
9.2.1 China Piperazine Sales by Application (2020-2031)
9.2.2 China Piperazine Revenue by Application (2020-2031)
10 Asia (excluding China)
10.1 Asia Market Size by Type
10.1.1 Asia Piperazine Sales by Type (2020-2031)
10.1.2 Asia Piperazine Revenue by Type (2020-2031)
10.2 Asia Market Size by Application
10.2.1 Asia Piperazine Sales by Application (2020-2031)
10.2.2 Asia Piperazine Revenue by Application (2020-2031)
10.3 Asia Market Size by Region
10.3.1 Asia Piperazine Revenue by Region: 2020 VS 2024 VS 2031
10.3.2 Asia Piperazine Revenue by Region (2020-2031)
10.3.3 Asia Piperazine Sales by Region (2020-2031)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Market Size by Type
11.1.1 Middle East, Africa and Latin America Piperazine Sales by Type (2020-2031)
11.1.2 Middle East, Africa and Latin America Piperazine Revenue by Type (2020-2031)
11.2 Middle East, Africa and Latin America Market Size by Application
11.2.1 Middle East, Africa and Latin America Piperazine Sales by Application (2020-2031)
11.2.2 Middle East, Africa and Latin America Piperazine Revenue by Application (2020-2031)
11.3 Middle East, Africa and Latin America Market Size by Country
11.3.1 Middle East, Africa and Latin America Piperazine Revenue by Country: 2020 VS 2024 VS 2031
11.3.2 Middle East, Africa and Latin America Piperazine Revenue by Country (2020-2031)
11.3.3 Middle East, Africa and Latin America Piperazine Sales by Country (2020-2031)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profile
12.1 Akzo Nobel
12.1.1 Akzo Nobel Corporation Information
12.1.2 Akzo Nobel Overview
12.1.3 Akzo Nobel Piperazine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.4 Akzo Nobel Piperazine Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Akzo Nobel Recent Developments
12.2 Dow Chemicals
12.2.1 Dow Chemicals Corporation Information
12.2.2 Dow Chemicals Overview
12.2.3 Dow Chemicals Piperazine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.4 Dow Chemicals Piperazine Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Dow Chemicals Recent Developments
12.3 BASF
12.3.1 BASF Corporation Information
12.3.2 BASF Overview
12.3.3 BASF Piperazine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.4 BASF Piperazine Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 BASF Recent Developments
12.4 Tosoh
12.4.1 Tosoh Corporation Information
12.4.2 Tosoh Overview
12.4.3 Tosoh Piperazine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.4 Tosoh Piperazine Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Tosoh Recent Developments
12.5 Delamine
12.5.1 Delamine Corporation Information
12.5.2 Delamine Overview
12.5.3 Delamine Piperazine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.4 Delamine Piperazine Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Delamine Recent Developments
12.6 Nippon Nyukazai
12.6.1 Nippon Nyukazai Corporation Information
12.6.2 Nippon Nyukazai Overview
12.6.3 Nippon Nyukazai Piperazine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.4 Nippon Nyukazai Piperazine Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Nippon Nyukazai Recent Developments
12.7 Diamines And Chemicals Limited (DACL)
12.7.1 Diamines And Chemicals Limited (DACL) Corporation Information
12.7.2 Diamines And Chemicals Limited (DACL) Overview
12.7.3 Diamines And Chemicals Limited (DACL) Piperazine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.4 Diamines And Chemicals Limited (DACL) Piperazine Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Diamines And Chemicals Limited (DACL) Recent Developments
12.8 Hebei Hejia Pharmaceutical Group
12.8.1 Hebei Hejia Pharmaceutical Group Corporation Information
12.8.2 Hebei Hejia Pharmaceutical Group Overview
12.8.3 Hebei Hejia Pharmaceutical Group Piperazine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.4 Hebei Hejia Pharmaceutical Group Piperazine Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Hebei Hejia Pharmaceutical Group Recent Developments
12.9 Shaoxing Xingxin New Materials Co.,Ltd
12.9.1 Shaoxing Xingxin New Materials Co.,Ltd Corporation Information
12.9.2 Shaoxing Xingxin New Materials Co.,Ltd Overview
12.9.3 Shaoxing Xingxin New Materials Co.,Ltd Piperazine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.4 Shaoxing Xingxin New Materials Co.,Ltd Piperazine Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Shaoxing Xingxin New Materials Co.,Ltd Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Piperazine Industry Chain Analysis
13.2 Piperazine Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Piperazine Production Mode & Process
13.4 Piperazine Sales and Marketing
13.4.1 Piperazine Sales Channels
13.4.2 Piperazine Distributors
13.5 Piperazine Customers
14 Piperazine Market Dynamics
14.1 Piperazine Industry Trends
14.2 Piperazine Market Drivers
14.3 Piperazine Market Challenges
14.4 Piperazine Market Restraints
15 Key Findings in the Global Piperazine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Piperazine market size was US$ 89.31 million in 2025 and is forecast to reach a readjusted size of US$ 110 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 79
USD 4250.00
(Single User License)
The global Piperazine market is projected to grow from US$ 89.31 million in 2025 to US$ 110 million by 2032, at a CAGR of 3.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 133
USD 4900.00
(Single User License)
The global market for Piperazine was estimated to be worth US$ 89.31 million in 2025 and is projected to reach US$ 110 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 98
USD 3950.00
(Single User License)
The global Piperazine market was valued at US$ 89.31 million in 2025 and is anticipated to reach US$ 110 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 134
USD 2900.00
(Single User License)
The global Piperazine market is projected to grow from US$ 87.7 million in 2024 to US$ 107 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 144
USD 4900.00
(Single User License)
The global market for Piperazine was estimated to be worth US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 107 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-05-01
Pages: 109
USD 3950.00
(Single User License)
The global Piperazine market size was US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 107 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-05-01
Pages: 78
USD 4250.00
(Single User License)
The global market for Piperazine was valued at US$ 87.7 million in the year 2024 and is projected to reach a revised size of US$ 107 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-05-01
Pages: 92
USD 2900.00
(Single User License)
The global market for Piperazine was estimated to be worth US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 101 million by 2031 with a CAGR of 2.1% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 125
USD 3950.00
(Single User License)
Piperazine (PIP; CAS 110-85-0) is a cyclic ethylene amine with two secondary amine groups. In its pure form, PIP has a freezing point of 106°C and a boiling point of 148°C.
Published Date: 2024-04-15
Pages: 105
USD 4900.00
(Single User License)
The global Piperazine market size was US$ 89.31 million in 2025 and is forecast to reach a readjusted size of US$ 110 million by 2032 with a CAGR of 3.1% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 79
The global Piperazine market is projected to grow from US$ 89.31 million in 2025 to US$ 110 million by 2032, at a CAGR of 3.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 133
The global market for Piperazine was estimated to be worth US$ 89.31 million in 2025 and is projected to reach US$ 110 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-03-05
Pages: 98
The global Piperazine market was valued at US$ 89.31 million in 2025 and is anticipated to reach US$ 110 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-03-05
Pages: 134
The global Piperazine market is projected to grow from US$ 87.7 million in 2024 to US$ 107 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 144
The global market for Piperazine was estimated to be worth US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 107 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-05-01
Pages: 109
The global Piperazine market size was US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 107 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-05-01
Pages: 78
The global market for Piperazine was valued at US$ 87.7 million in the year 2024 and is projected to reach a revised size of US$ 107 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-05-01
Pages: 92
The global market for Piperazine was estimated to be worth US$ 87.7 million in 2024 and is forecast to a readjusted size of US$ 101 million by 2031 with a CAGR of 2.1% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 125
Piperazine (PIP; CAS 110-85-0) is a cyclic ethylene amine with two secondary amine groups. In its pure form, PIP has a freezing point of 106°C and a boiling point of 148°C.
Published: 2024-04-15
Pages: 105
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now